Solid Tumors
Showing NaN - NaN of 39
Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)
Recruiting
- Advanced Malignancies
- +4 more
- Avelumab
- +7 more
-
Fayetteville, Arkansas
- +61 more
Jan 10, 2023
Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- ASP9801
- Pembrolizumab
-
Birmingham, Alabama
- +26 more
Jan 6, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in Spain, United Kingdom, United States (Azacitidine,
Solid Tumors Trial in Worldwide (Tivozanib + paclitaxel, Tivozanib + temsirolimus, Tivozanib)
Terminated
- Solid Tumors
- Tivozanib + paclitaxel
- +5 more
-
Scottsdale, Arizona
- +48 more
Aug 17, 2020
Solid Tumors Trial in Baltimore, Philadelphia (ACE 011)
Terminated
- Solid Tumors
- ACE 011
-
Baltimore, Maryland
- +2 more
Oct 30, 2019
Solid Tumors, Pancreatic Cancer Trial in United States (itacitinib, Gemcitabine, nab-paclitaxel)
Completed
- Solid Tumors
- Pancreatic Cancer
- itacitinib
- +3 more
-
Scottsdale, Arizona
- +7 more
Jul 16, 2019
Solid Tumors Trial in United States (Ramucirumab (IMC-1121B), Irinotecan, Folinic acid)
Completed
- Solid Tumors
- Ramucirumab (IMC-1121B)
- +3 more
-
Detroit, Michigan
- +4 more
Feb 3, 2019
Pediatrics, Solid Tumors Trial in United States (Eribulin Mesylate)
Completed
- Pediatrics
- Solid Tumors
- Eribulin Mesylate
-
Birmingham, Alabama
- +17 more
Jan 2, 2019